Search

everythinglearnresearchcommunity

for

Search:↓

Interest in long-COVID symptoms in Japan increased with COVID-19 case peaks, especially for hair loss, cough, smell/taste issues, and headache.

Anti-androgen therapy might help protect against COVID-19 infection and reduce death risk.

There's no significant genetic link between male pattern baldness and COVID-19.

Common dermatology drugs were considered but are controversial for COVID-19 treatment.

Cepharanthine is safe but not effective in significantly reducing COVID-19 recovery time.

Male hormones may increase the severity and death rates of COVID-19.

Nailfold dermoscopy is a simple, cheap way to check blood vessel changes in COVID-19 patients.

Beau's lines on fingernails might indicate past severe COVID-19 and risk of reinfection.

PRP therapy can effectively treat hair loss after COVID-19 vaccination.

Most people in South India lack knowledge about managing COVID-19 at home.

Androgen deprivation therapy might help prevent severe COVID-19, but more research is needed.

New A-homo-B, 19-dinor steroids showed strong antiandrogenic activity without affecting the enzyme 5α-reductase or androgen receptor binding.

FMH foods may help manage post-acute COVID-19 symptoms safely and easily.

Cepharanthine is safe but not clearly effective in speeding up COVID-19 recovery.

The skin conditions of Iraqi women changed during the COVID-19 pandemic, with more hair loss and skin irritation but fewer contagious skin infections.

Men with androgenetic alopecia and hypertension may experience more severe COVID-19.

Training programs are needed to improve home COVID-19 management practices.

Public interest in hair loss increased during the COVID-19 pandemic.

A combination of arginine silicate complex and magnesium biotinate improves hair and nail growth in rats.

S-equol supplements significantly reduced menopausal symptoms in most women.

A patient with Ehlers-Danlos Syndrome improved after treatment for fat malabsorption and essential fatty acid deficiency.

More skin issues appeared in the emergency department during COVID-19, highlighting the need for better dermatology training and resources.

Androgenetic alopecia is linked to a higher risk of metabolic syndrome.

Hair loss was the most common skin issue among healthcare workers with COVID-19.

Severe hair loss may increase the risk of dying from COVID-19.

Transcranial electrical stimulation may help reduce certain immune markers in COVID-19 patients.

More people experience hair loss after recovering from COVID-19 in hospitals than in outpatient settings.

Targeted interventions based on gender, education, and age can improve COVID-19 healthcare responses.